nitial €50,000 Phase 1 grant will fund full feasibility study Symcel: Symcel, the company behind the revolutionary cell-based assay tool for real-time cellular bioenergetic measurements,calScreener™, has secured Horizon 2020 Phase I funding to prepare the company for the planned commercialisation of its groundbreaking technology. The €50,000 Phase 1 grant will fund a full feasibility study. […]
Zurich / Glattbrugg | A groundbreaking new method for single cell analysis based on FluidFM® technology allows scientist to investigate the behavior of individual cells within their natural environment. The new method has been developed at ETH Zurich and could revolutionize biological research as it opens up a completely new dimension for the study of […]
A groundbreaking new method for single cell analysis based on FluidFM® technology allows scientist to investigate the behavior of individual cells within their natural environment. The new method has been developed at ETH Zurich and could revolutionize biological research as it opens up a completely new dimension for the study of individual cells. The new […]
Cleaver Scientific announces proSET – an innovative new range of benchtop scale fermentation systems designed to provide an optimized cell cultivation solution for applications including growth of sensitive and fragile mammalian and insect cells. Incorporating a large, colour touchscreen panel with an intuitive software interface, proSET fermentation systems are very user friendly allowing productive use […]
Corning Incorporated (NYSE: GLW) subsidiary, Mediatech, Inc., and Biological Industries, Ltd. (BI) announced an agreement to enable cell therapy research and manufacturing organizations to purchase the innovative, xeno-free human pluripotent stem-cell (hPSC) medium in conjunction with Corning’s other leading stem-cell culture products. “This product augments our growing portfolio of media and reagents, and our technical […]
AMSBIO has introduced new cell lines and controls for Programmed Cell Death Protein 1 (PD-1) research, and to test inhibitors of the PD-1 / PD-L1 pathway. The binding of PD-1, a receptor expressed on activated T-cells, to its ligands (PD-L1 and PD-L2) negatively regulates immune responses. PD-1 ligands are highly expressed in many cancers, and […]
Lophius’ new ready-to-coat MultiTrack microtiter plates are optimized to prepare and carry out ELISpot assays for research and diagnostic applications in the field of immunology, infectious diseases, transplantation, oncology and autoimmune diseases. Optimized for individual ELISpot assays, the MultiTrack plates allow maximum flexibility in assay configuration due to its Click-in frame with 12 x 8-well […]
BERGISCH GLADBACH, – Miltenyi Biotec has extended its portfolio with the MACSPlex Exosome Kit, human. The fast and efficient process enables the characterization of 37 exosome surface markers in a single experiment. Studies indicate that the physiological significance of exosomes is not to be ignored. The molecular content that is passed from one cell to […]
Albuquerque, New Mexico – IntelliCyt, a leading provider of integrated platforms that accelerate drug discovery, antibody discovery, and immuno-oncology research, announced a collaboration with Notable Labs to further the development of a predictive personalized medicine platform. Notable Labs helps oncologists identify effective therapies that they can prescribe today by testing them on a patient’s own […]
AMSBIO has introduced new cell lines and controls for Programmed Cell Death Protein 1 (PD-1) research, and to test inhibitors of the PD-1 / PD-L1 pathway. The binding of PD-1, a receptor expressed on activated T-cells, to its ligands (PD-L1 and PD-L2) negatively regulates immune responses. PD-1 ligands are highly expressed in many cancers, and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
